Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections

Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections

US Patent 8399496 · Granted Mar 19, 2013

Estimated economic value: $449,562,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

For measuring the axial (transverse), coronal (frontal) and sagittal (bisection)2025
Beta-hairpin peptidomimetic with elastase inhibitory activity and aerosol dosage2023
Beta-hairpin peptidomimetic with elastase inhibitory activity and aerosol dosage2022
Beta-hairpin peptidomimetic with elastase inhibitory activity and aerosol dosage2022
Methods of treating respiratory syncytial virus infections2020
Formulations of aminoglycoside and fosfomycin in combination for treatment of ve2019
Formulations of aminoglycosides and fosfomycin in a combination having improved 2019
Mast cell stabilizers treatment for systemic disorders2019
Mast cell stabilizers treatment for systemic disorders2019
Mast cell stabilizers treatment for systemic disorders2018
Mast cell stabilizers treatment for systemic disorders2018
Aerosols for sinunasal drug delivery2017